The unique ability to specifically bind to the nucleic acid sequence makes oligonucleotide (ON) a promising agent in the medical field. Moreover, the capability of ONs to exert the aforementioned biological mechanisms via sequence-specific molecular recognition makes them highly attractive candidates for drug development. Here are Top 10 companies in oligonucleotide – Danaher Corporation Founded […]Read More..
The global research antibodies and reagents market is expected to grow at a CAGR of 6.5% from 2018 to 2023 to reach USD 13,276.5 million by 2023, says “Meticulous Research” Traditionally, antibodies were obtained from blood and serum. However, these antibodies were produced in limited number and may cause cross-reactivity. This led to increase their […]Read More..
With the arrival of the industrial revolution, life sciences industry embarks the new phase of transformation in technologies. Growing strategic alliances, advancements in technologies, and progress in the availability of useful tools have significantly impacted various sectors of life sciences such as pharmaceutical, biotech, and healthcare. As per the recent research by Meticulous Research, the life […]Read More..
Cloning is a process used to produce genetically identical copies of a biological entity. These copies are referred to as clones. Since last decade, researchers are cloning a wide range of biological material namely genes, cells, tissues, or entire organisms. For this, the natural competence of a cell or bacteria or genome is highly important […]Read More..
The recent developments in genomics sequencing technologies have the potential to transform the diagnosis and treatment of many diseases, specifically inherited and cancers. Medicines based on clinical genomics companies are making inroads in the fields of oncology, infection, pharmacology, and rare and undiagnosed diseases. Moreover, the genetic variants in the human genome, both at the […]Read More..